Tiny bladder implant, TAR-200, eliminates cancer in 82% of patients

Credit: Johnson & Johnson

The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer, offering a promising new treatment approach

A small…

Continue Reading